Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., has announced that it has entered into a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), with Steven A. Rosenberg, M.D., Ph.D., chief, Surgery Branch, serving as the NCI principal investigator, to research and develop novel cell therapy technologies as potential treatments for a variety of cancers.
Lees meer..

In the sense that organisms existing today are connected through a chain of life - through their parents, grandparents and other ancestors - almost a billion years back to the first animals of the pre-Cambrian era, an animal’s reproductive cells can be considered to be immortal.
Lees meer..

In the battle against cancer, allies can come from unexpected sources. Research at The Jackson Laboratory has yielded a new approach to treating leukemia, one that targets leukemia-proliferating cells with drugs that are already on the market. Jackson Adjunct Professor Shaoguang Li, M.D., Ph.D.
Lees meer..

Scientists in Michigan and California are reporting an advance toward development of a new generation of drugs that treat disease by orchestrating how genes in the body produce proteins involved in arthritis, cancer and a range of other disorders. Acting like an “on-off switch,” the medications might ratchet up the production of proteins in genes working at abnormally low levels or shut off genes producing an abnormal protein linked to disease.
Lees meer..

Science fact meets science fiction as experts imagine a future without animal research and how we might get there - at this year’s Cheltenham Science Festival. The event**, organised by New Scientist and the NC3Rs, will explore the latest advances in research that are being harnessed to reduce our use of animals, and how such technologies might develop in the future.
Lees meer..

A well-crafted case study is a powerful educational and marketing tool. The Pharmacy Benefit Management Institute’s (PBMI) 15th Anniversary Drug Benefit Conference offers industry experts an opportunity to present case studies that showcase solutions to critical drug benefit challenges. Speaker proposals will be accepted until August 14, 2009 for the conference to be held February 17-19, 2010 in Phoenix.
Lees meer..

Like human infants, young apes are known to hoot and holler when you tickle them. But is it fair to say that those playful calls are really laughter? The answer to that question is yes, say researchers reporting online on June 4th in Current Biology, a Cell Press publication. “This study is the first phylogenetic test of the evolutionary continuity of a human emotional expression,” said Marina Davila Ross of the University of Portsmouth in the United Kingdom.
Lees meer..

A pair of Michigan State University professors have received a total of nearly $400,000 for their cardiovascular research projects as part of the first wave of stimulus funding from federal agencies. The money, from the National Institutes of Health via the American Recovery and Reinvestment Act, will help to preserve and create jobs in Michigan while also investing in important medical research, said U.S. Sen. Carl Levin, whose office announced the awards.
Lees meer..

On the 4th June, the Faculty of Health Sciences at the University of Copenhagen will open the doors of its new research center, The Novo Nordisk Foundation Center for Protein Research. The Center is the result of a historic donation from the Novo Nordisk Foundation, which in 2007 gave the University 80 million euros for its establishment.
Lees meer..

Researchers at the University of California, San Diego School of Medicine have developed the first mouse model for auto-inflammatory diseases, disorders that involve the over-activation of the body’s innate, primitive immune system. Their study, published early on-line in Cell Immunity on June 4, suggests that the innate - not adaptive - immune system drives auto-inflammatory diseases.
Lees meer..